Clinical trial
Tolerance of Intra-articular Injection Autologous Stromal Vascular Fraction for the Treatment of Rhizarthrosis
NCT05708430 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tolerance of Intra-articular Injection Autologous Stromal Vascular Fraction for the Treatment of Rhizarthrosis
- Lead sponsor
- University Hospital, Rouen
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- February 15, 2024
- Completion date
- December 31, 2026
- Enrollment
- 12 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
rhizarthrosis